Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

30
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
30
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

16
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
16
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

57
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
57
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

34
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
34
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

28
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
28
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

22
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
22

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Colchicine in coronary heart disease: from inflammatory biology to secondary prevention.

Clinical and experimental rheumatology·2026
Same author

Incidental cardiac mass: when the past influences the future.

European heart journal. Imaging methods and practice·2026
Same author

One echocardiographic or hemodynamic parameter improves mortality prediction by the ESC/ERS four-strata model: a flexible approach to follow-up risk stratification in pulmonary arterial hypertension.

European heart journal. Quality of care & clinical outcomes·2026
Same author

Arrhythmic Myocarditis and Prevention of Sudden Cardiac Death: Current Evidence, Risk Stratification, and Management.

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese·2026
Same author

Management of pericarditis: recent advances.

Polish archives of internal medicine·2026
Same author

[Ten clinical questions about recurrent or incessant pericarditis].

Giornale italiano di cardiologia (2006)·2026

Related Experiment Video

Updated: Sep 13, 2025

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice
04:45

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice

Published on: May 5, 2022

2.6K

Inflammatory cardiomyopathy: an update for clinicians.

Massimo Imazio1

  • 1Department of Medicine, University of Udine, Italy; Cardiothoracic Department, University Hospital Santa Maria della Misericordia, ASUFC, Udine, Italy.

Trends in Cardiovascular Medicine
|July 27, 2025
PubMed
Summary

Inflammatory cardiomyopathy (CMP) involves persistent heart inflammation causing dysfunction. Integrated diagnosis with genetic testing and cardiac imaging improves risk assessment and treatment for this heterogeneous condition.

Keywords:
Cardiac magnetic resonanceEndomyocardial biopsyInflammatory cardiomyopathyMyocarditis

More Related Videos

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

7.8K
Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

2.7K

Related Experiment Videos

Last Updated: Sep 13, 2025

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice
04:45

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice

Published on: May 5, 2022

2.6K
Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

7.8K
Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

2.7K

Area of Science:

  • Cardiology
  • Immunology
  • Genetics

Background:

  • Inflammatory cardiomyopathy (CMP) is a myocardial disorder characterized by persistent inflammation, ventricular dysfunction, and remodeling.
  • It often evolves from acute myocarditis, with multifactorial pathogenesis involving viral triggers, immune responses, and genetic factors.
  • CMP presents with a broad clinical spectrum, including arrhythmias and heart failure.

Purpose of the Study:

  • To highlight the integrated diagnostic approach for inflammatory cardiomyopathy.
  • To emphasize the role of genetic testing in diagnosis, risk stratification, and treatment decisions.
  • To discuss the prognostic factors and future research directions in CMP.

Main Methods:

  • Integrated diagnostic approach combining clinical evaluation, ECG, biomarkers, and multimodality imaging (cardiac magnetic resonance - CMR).
  • Endomyocardial biopsy (EMB) as the gold standard for histologic subtyping and guiding therapy.
  • Inclusion of genetic testing to identify pathogenic variants predisposing to myocardial inflammation.

Main Results:

  • Diagnosis requires a multimodal strategy, with EMB crucial for histologic confirmation and therapy guidance.
  • Genetic testing plays a key role in diagnosis, risk stratification, and predicting outcomes in recurrent cases.
  • Prognosis is linked to disease severity, fibrosis, and etiology.

Conclusions:

  • Inflammatory cardiomyopathy is a heterogeneous condition requiring an integrated diagnostic approach.
  • Genetic testing is essential for comprehensive management and outcome prediction.
  • Precision diagnostics and immunomodulatory treatments offer promise for improving outcomes in potentially reversible CMP.